McKesson acquires Canadian pharmacy operator Rexall
San Francisco: Prescription drug distributor McKesson Corp. is buying Canadian pharmacy operator Rexall Health from Katz Group for $2.2 billion, strengthening McKesson's Canadian pharmaceutical supply chain.
The deal would be worth about $1.9 billion after tax benefits. It is expected to close late this year.
San Francisco-based McKesson will acquire about 470 of Rexall's retail pharmacies, bolstering its Canadian operations and bringing the number of employees at its Canadian unit to 13,000.
Shares in McKesson rose almost 2 percent in afternoon trading.
The deal would be worth about $1.9 billion after tax benefits. It is expected to close late this year.
San Francisco-based McKesson will acquire about 470 of Rexall's retail pharmacies, bolstering its Canadian operations and bringing the number of employees at its Canadian unit to 13,000.
Shares in McKesson rose almost 2 percent in afternoon trading.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd